Predictors of benefit in colorectal cancer treated with cetuximab: Are we getting "lost in translationAL"?

Chiara Cremolini, Fotios Loupakis, Annamaria Ruzzo, Giuseppe Perrone, Eliana Rulli, Bruno Vincenzi, Giuseppe Tonini, Francesco Graziano, Andrea Onetti Muda, Alfredo Falcone

Research output: Contribution to journalArticle

Original languageEnglish
JournalJournal of Clinical Oncology
Volume28
Issue number11
DOIs
Publication statusPublished - Apr 10 2010

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Cremolini, C., Loupakis, F., Ruzzo, A., Perrone, G., Rulli, E., Vincenzi, B., Tonini, G., Graziano, F., Muda, A. O., & Falcone, A. (2010). Predictors of benefit in colorectal cancer treated with cetuximab: Are we getting "lost in translationAL"? Journal of Clinical Oncology, 28(11). https://doi.org/10.1200/JCO.2009.26.6148